Different electrophysiological actions of 24- and 72-hour aggregated amyloid-beta oligomers on hippocampal field population spike in both anesthetized and awake rats

Brain Research

Volumn 1354, Issue , 2010, Pages 227-235

  Orbán, Gergely ^a   Völgyi, Katalin ^a   Juhász, Gábor ^a   Penke, Botond ^b   Kékesi, Katalin Adrienna ^a   Kardos, József ^a   Czurkó, András ^a,b  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Alzheimer's disease; Amyloid; Atomic force microscopy; Excitability; Oligomer

Indexed keywords

AMYLOID BETA PROTEIN[1-42];

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; EXCITABILITY; HIPPOCAMPUS; MALE; NERVE CELL; NEUROPROTECTION; NONHUMAN; OLIGOMERIZATION; PERFORANT NERVE TRACT; PRIORITY JOURNAL; RAT; WAKEFULNESS;

AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; ANIMALS; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; HIPPOCAMPUS; MALE; MICROSCOPY, ATOMIC FORCE; NEURONS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; MUS MUSCULUS; RATTUS;

EID: 77956413704     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.07.061     Document Type: Article

References (49)

1. P. Andersen, T.V. Bliss, and K.K. Skrede Unit analysis of hippocampal polulation spikes Exp. Brain Res. 13 1971 208 221
2. M.A. Busche, G. Eichhoff, H. Adelsberger, D. Abramowski, K.H. Wiederhold, C. Haass, M. Staufenbiel, A. Konnerth, and O. Garaschuk Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease Science 321 2008 1686 1689
3. J.P. Cleary, D.M. Walsh, J.J. Hofmeister, G.M. Shankar, M.A. Kuskowski, D.J. Selkoe, and K.H. Ashe Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function Nat. Neurosci. 8 2005 79 84
4. K.N. Dahlgren, A.M. Manelli, W.B. Stine Jr., L.K. Baker, G.A. Krafft, and M.J. LaDu Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability J. Biol. Chem. 277 2002 32046 32053
5. P.P. DeMager, B. Penke, R. Walter, T. Harkany, and W. Hartignny Pathological peptide folding in Alzheimer's disease and other conformational disorders Curr. Med. Chem. 9 2002 1763 1780
6. V.H. Finder, and R. Glockshuber Amyloid-beta aggregation Neurodegener. Dis. 4 2007 13 27
7. A. Frick, J. Magee, and D. Johnston LTP is accompanied by an enhanced local excitability of pyramidal neuron dendrites Nat. Neurosci. 7 2004 126 135
8. C. Frieden Protein aggregation processes: in search of the mechanism Protein Sci. 16 2007 2334 2344
9. F. Gallyas, M. Hsu, and G. Buzsáki Four modified silver methods for thick sections of formaldehyde-fixed mammalian central nervous tissue: 'dark' neurons, perikarya of all neurons, microglial cells and capillaries J. Neurosci. Methods 2 1993 159 164
10. G.G. Glenner, C.W. Wong, V. Quaranta, and E.D. Eanes The amyloid deposits in Alzheimer's disease: their nature and pathogenesis Appl. Pathol. 2 1984 357 369
11. T.A. Good, and R.M. Murphy Effect of beta-amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron Proc. Natl. Acad. Sci. U. S. A. 93 1996 15130 15135
12. C. Haass, and D.J. Selkoe Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide Nat. Rev. Mol. Cell Biol. 8 2007 101 112
13. J.D. Harper, S.S. Wong, C.M. Lieber, and P.T. Lansbury Observation of metastable Abeta amyloid protofibrils by atomic force microscopy Chem. Biol. 4 1997 119 125
14. D.M. Hartley, D.M. Walsh, C.P. Ye, T. Diehl, S. Vasquez, P.M. Vassilev, D.B. Teplow, and D.J. Selkoe Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons J. Neurosci. 19 1999 8876 8884
15. M. Hermes, G. Eichhoff, and O. Garaschuk Intracellular calcium signalling in Alzheimer's disease J. Cell. Mol. Med. 14 2010 30 41
16. N. Innocent, N. Evans, C. Hille, and S. Wonnacott Oligomerisation differentially affects the acute and chronic actions of amyloid-ß in vitro Neuropharmacology 59 2010 343 352
17. M.D. Kirkitadze, G. Bitan, and D.B. Teplow Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies J. Neurosci. Res. 69 2002 567 577
18. W.L. Klein, W.B. Stine Jr., and D.B. Teplow Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease Neurobiol. Aging 25 2004 569 580
19. P.N. Lacor, M.C. Buniel, L. Chang, S.J. Fernandez, Y. Gong, K.L. Viola, M.P. Lambert, P.T. Velasco, E.H. Bigio, C.E. Finch, G.A. Krafft, and W.L. Klein Synaptic targeting by Alzheimer's-related amyloid beta oligomers J. Neurosci. 24 2004 10191 10200
20. A.J. Larner Epileptic seizures in AD patients Neuromolecular Med. 12 2010 71 77
21. C.L. Masters, G. Simms, N.A. Weinman, G. Multhaup, B.L. McDonald, and K. Beyreuther Amyloid plaque core protein in Alzheimer disease and Down syndrome Proc. Natl. Acad. Sci. U. S. A. 82 1985 4245 4249
22. J.M. Mc Donald, G.M. Savva, C. Brayne, A.T. Welzel, G. Forster, G.M. Shankar, D.J. Selkoe, P.G. Ince, and D.M. Walsh The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia Brain 133 2010 1328 1341
23. C.A. McLean, R.A. Cherny, F.W. Fraser, S.J. Fuller, M.J. Smith, K. Beyreuther, A.I. Bush, and C.L. Masters Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease Ann. Neurol. 46 1999 860 866
24. R. Minkeviciene, S. Rheims, M.B. Dobszay, M. Zilberter, J. Hartikainen, L. Fulop, B. Penke, Y. Zilberter, T. Harkany, A. Pitkanen, and H. Tanila Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy J. Neurosci. 29 2009 3453 3462
25. Z. Molnar, K. Soos, I. Lengyel, B. Penke, V. Szegedi, and D. Budai Enhancement of NMDA responses by beta-amyloid peptides in the hippocampus in vivo NeuroReport 15 2004 1649 1652
26. H. Naiki, and F. Gejyo Kinetic analysis of amyloid fibril formation Methods Enzymol. 309 1999 305 318
27. P.K. Nandi Protein conformation and disease Vet. Res. 27 1996 373 382
28. V. Nimmrich, C. Grimm, A. Draguhn, S. Barghorn, A. Lehmann, H. Schoemaker, H. Hillen, G. Gross, U. Ebert, and C. Bruehl Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents J. Neurosci. 28 2008 788 797
29. J.J. Palop, J. Chin, E.D. Roberson, J. Wang, M.T. Thwin, N. Bien-Ly, J. Yoo, K.O. Ho, G.Q. Yu, A. Kreitzer, S. Finkbeiner, J.L. Noebels, and L. Mucke Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease Neuron 55 2007 697 711
30. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 1986 Academic Press Sydney
31. M. Ramsden, L.D. Plant, N.J. Webster, P.F. Vaughan, Z. Henderson, and H.A. Pearson Differential effects of unaggregated and aggregated amyloid beta protein (1-40) on K(+) channel currents in primary cultures of rat cerebellar granule and cortical neurones J. Neurochem. 79 2001 699 712
32. G. Riedel, T. Seidenbecher, and K.G. Reymann LTP in hippocampal CA1 of urethane-narcotized rats requires stronger tetanization parameters Physiol. Behav. 55 1994 1141 1146
33. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791
34. D.J. Selkoe Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior Behav. Brain Res. 192 2008 106 113
35. G.M. Shankar, S. Li, T.H. Mehta, A. Garcia-Munoz, N.E. Shepardson, I. Smith, F.M. Brett, M.A. Farrell, M.J. Rowan, C.A. Lemere, C.M. Regan, D.M. Walsh, B.L. Sabatini, and D.J. Selkoe Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat. Med. 14 2008 837 842
36. D.H. Small Dysregulation of calcium homeostasis in Alzheimer's disease Neurochem. Res. 34 2009 1824 1829
37. W.B. Stine Jr., K.N. Dahlgren, G.A. Krafft, and M.J. LaDu In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis J. Biol. Chem. 278 2003 11612 11622
38. R.E. Tanzi The synaptic Abeta hypothesis of Alzheimer disease Nat. Neurosci. 8 2005 977 979
39. K. Ueda, S. Shinohara, T. Yagami, K. Asakura, and K. Kawasaki Amyloid beta protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals J. Neurochem. 68 1997 265 271
40. Y. Verdier, and B. Penke Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer's disease Curr. Protein Pept. Sci. 5 2004 19 31
41. D.M. Walsh, and D.J. Selkoe Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration Protein Pept. Lett. 11 2004 213 228
42. D.M. Walsh, and D.J. Selkoe A beta oligomers-a decade of discovery J. Neurochem. 101 2007 1172 1184
43. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S. Wolfe, M.J. Rowan, and D.J. Selkoe Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
44. J. Wu, R. Anwyl, and M.J. Rowan beta-Amyloid-(1-40) increases long-term potentiation in rat hippocampus in vitro Eur. J. Pharmacol. 284 1995 R1 R3
45. J. Wu, R. Anwyl, and M.J. Rowan beta-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus NeuroReport 6 1995 2409 2413
46. C. Ye, D.M. Walsh, D.J. Selkoe, and D.M. Hartley Amyloid beta-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-D-aspartate (NMDA) versus non-NMDA receptor/channel activation Neurosci. Lett. 366 2004 320 325
47. J.T. Yu, R.C. Chang, and L. Tan Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities Prog. Neurobiol. 89 2009 240 255
48. S.H. Yun, G. Gamkrelidze, W.B. Stine, P.M. Sullivan, J.F. Pasternak, M.J. Ladu, and B.L. Trommer Amyloid-beta1-42 reduces neuronal excitability in mouse dentate gyrus Neurosci. Lett. 403 2006 162 165
49. M. Zarandi, K. Soos, L. Fulop, Z. Bozso, Z. Datki, G.K. Toth, and B. Penke Synthesis of Abeta[1-42] and its derivatives with improved efficiency J. Pept. Sci. 13 2007 94 99